Literature DB >> 24275079

Microcirculatory perfusion shift in the gut wall layers induced by extracorporeal circulation.

Johannes Kalder1, Dieudonne Ajah1, Paula Keschenau1, Lieven N Kennes2, Rene Tolba3, Maria Kokozidou1, Michael J Jacobs4, Thomas A Koeppel1.   

Abstract

OBJECTIVE: Extracorporeal circulation (ECC) is regularly applied to maintain organ perfusion during major aortic and cardiovascular surgery. During thoracoabdominal aortic repair, ECC-driven selective visceral arterial perfusion (SVP) results in changed microcirculatory perfusion (shift from the muscularis toward the mucosal small intestinal layer) in conjunction with macrohemodynamic hypoperfusion. The underlying mechanism, however, is unclear. Therefore, the aim of this study was to assess in a porcine model whether ECC itself or the hypoperfusion induced by SVP is responsible for the mucosal/muscular shift in the small intestinal wall.
METHODS: A thoracoabdominal aortic approach was performed in 15 healthy pigs divided equally into three groups: group I, control; group II, thoracic aortic cross-clamping with distal aortic perfusion; and group III, thoracic aortic cross-clamping with distal aortic perfusion and SVP. Macrocirculatory and microcirculatory blood flow was assessed by transit time ultrasound volume flow measurement and fluorescent microspheres. In addition, markers for metabolism and intestinal ischemia-reperfusion injury were determined.
RESULTS: ECC with a roller pump induced a significant switch from the muscularis and mucosal layer of the small intestine, even with adequate macrocirculation (mucosal/muscular perfusion ratio: group I vs II, P = .005; group I vs III, P = .0018). Furthermore, the oxygen extraction ratio increased significantly in groups II (>30%) and III (>40%) in the beginning of the ECC compared with the control (group I vs II, P = .0037; group I vs III, P = .0062). Lactate concentrations and pH values did not differ between groups I and II; but group III demonstrated a significant shifting toward a lactate-associated acidosis (lactate: group I vs III, P = .0031; pH: group I vs III, P = .0001).
CONCLUSIONS: We demonstrated a significant shifting between the small intestinal gut wall layers induced by roller pump-driven ECC. The shift occurs independently of macrohemodynamics, with a significant effect on aerobic metabolism in the gut wall. Consequently, an optimal intestinal perfusion cannot be guaranteed by a roller pump; therefore, perfusion techniques need to be optimized.
Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24275079     DOI: 10.1016/j.jvs.2013.10.070

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Orthopedic Surgery Causes Gut Microbiome Dysbiosis and Intestinal Barrier Dysfunction in Prodromal Alzheimer Disease Patients: A Prospective Observational Cohort Study.

Authors:  Fangyan Liu; Mei Duan; Huiqun Fu; Guoguang Zhao; Ying Han; Fei Lan; Zara Ahmed; Guanglei Cao; Zheng Li; Daqing Ma; Tianlong Wang
Journal:  Ann Surg       Date:  2022-06-29       Impact factor: 13.787

Review 2.  State-of the-art review on the renal and visceral protection during open thoracoabdominal aortic aneurysm repair.

Authors:  Karl Waked; Marc Schepens
Journal:  J Vis Surg       Date:  2018-02-08

3.  Evaluation of the NMR-MOUSE as a new method for continuous functional monitoring of the small intestine during different perfusion states in a porcine model.

Authors:  Paula R Keschenau; Hanna Klingel; Silke Reuter; Ann Christina Foldenauer; Jochen Vieß; Dennis Weidener; Julia Andruszkow; Bernhard Bluemich; René Tolba; Michael J Jacobs; Johannes Kalder
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

4.  Feeding intolerance and risk of poor outcome in patients undergoing cardiopulmonary bypass surgery.

Authors:  Yanjuan Lin; Meihua Chen; Yanchun Peng; Qiong Chen; Sailan Li; Liangwan Chen
Journal:  Br J Nutr       Date:  2021-01-20       Impact factor: 3.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.